Lipid-based drug delivery systems, or lipidic carriers, are being extensively employed to
enhance the bioavailability of poorly-soluble drugs. They have the ability to incorporate both …

Cancer is a complex multifactorial disease that results from alterations in many physiological
and biochemical functions. Over the last few decades, it has become clear that cancer cells …

Multiple myeloma (MM) is the second most common hematological malignancy. It is
characterized by abnormal transformation and uncontrolled clonal proliferation of malignant …

Regeneration is a complex process affected by many elements independent or combined,
including inflammation, proliferation, and tissue remodeling. Stem cells is a class of primitive …

Triple negative breast cancers (TNBC) without BRCA1/2 gene mutation or BRCAness are
nowadays the breast malignancies most difficult to treat. Improvement of their treatment, for …

The review highlights the safety issues of drug delivery systems based on liposomes. Due to
their small sizes (about 80–120 nm, sometimes even smaller), phospholipid nanoparticles …

Malignant tumor has become one of the major diseases that seriously endangers human
health. Numerous studies have demonstrated that tumor microenvironment (TME) is closely …

Metastasis is the primary cause of death for most cancer patients, in which tumor-associated
macrophages (TAMs) are involved through several mechanisms. While hitherto there is still …

In order to enhance the targeting efficiency and reduce anti-tumor drug's side effects,
topotecan (TPT) and F7 were co-loaded in thermosensitive liposomes (F7-TPT-TSL), which …

Currently, multiple myeloma (MM) is a prevalent hematopoietic system malignancy, known
for its insidious onset and unfavorable prognosis. Recently developed chemotherapy drugs …